Propanc Biopharma Inc. (PPCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PPCH | AMGN | BMY | GILD | REGN |
| Company | Propanc Biopharma Inc. | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.3000 | 325.58 | 54.52 | 123.80 | 729.40 |
| High | 1.4200 | 331.34 | 54.91 | 126.24 | 737.87 |
| Low | 1.3000 | 321.71 | 53.88 | 122.28 | 718.38 |
| Latest | 1.3950 | 331.00 | 54.22 | 124.14 | 733.78 |
| Change | +0.1050 | +0.59 | -1.04 | -0.77 | +0.74 |
| % Change | +8.14% | +0.18% | -1.88% | -0.62% | +0.10% |
| Volume | 28,600 | 2,947,800 | 15,349,900 | 9,152,601 | 789,300 |
| 20-Day Average Volume | 42,490 | 2,763,105 | 14,221,415 | 6,573,665 | 869,665 |
| Previous Close | 1.2900 | 330.41 | 55.26 | 124.91 | 733.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2912 | 329.47 | 54.95 | 123.05 | 772.16 |
| 20-Day Raw Stochastic | 48.37% | 51.49% | 43.37% | 68.95% | 14.99% |
| 20-Day Relative Strength | 44.56 | 53.13 | 54.54 | 52.58 | 47.23 |
| Weighted Alpha | -76.68 | +21.09 | -0.28 | +29.45 | +18.24 |
| Today's Opinion | N/A | 80% Buy | 80% Buy | 72% Buy | 56% Buy |
| Previous Opinion | N/A | 64% Buy | 100% Buy | 72% Buy | 56% Buy |
| Last Month's Opinion | N/A | 72% Buy | 72% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.98% since 05/24/17 | +1.68% since 01/12/26 | -2.78% since 01/12/26 | +1.26% since 01/12/26 | -4.46% since 01/12/26 |
| Low | 1.1000 on 05/25/17 | 319.79 on 01/13/26 | 53.88 on 01/20/26 | 120.22 on 01/13/26 | 718.38 on 01/20/26 |
| High | 1.4200 on 05/31/17 | 333.03 on 01/16/26 | 57.04 on 01/14/26 | 126.24 on 01/20/26 | 766.64 on 01/14/26 |
| 1-Month | |||||
| %Chg | -29.19% since 04/28/17 | +1.11% since 12/19/25 | +0.06% since 12/19/25 | -0.12% since 12/19/25 | -4.45% since 12/19/25 |
| Low | 0.9500 on 05/11/17 | 318.21 on 01/05/26 | 52.06 on 01/05/26 | 116.88 on 01/05/26 | 718.38 on 01/20/26 |
| High | 1.9700 on 05/01/17 | 343.05 on 01/07/26 | 57.04 on 01/14/26 | 127.41 on 12/23/25 | 821.11 on 01/09/26 |
| 3-Month | |||||
| %Chg | -47.36% since 02/28/17 | +9.12% since 10/20/25 | +24.39% since 10/20/25 | +0.84% since 10/20/25 | +27.22% since 10/20/25 |
| Low | 0.9500 on 05/11/17 | 288.00 on 10/31/25 | 42.52 on 10/29/25 | 114.02 on 10/31/25 | 572.75 on 10/23/25 |
| High | 2.8750 on 03/03/17 | 346.38 on 12/03/25 | 57.04 on 01/14/26 | 128.70 on 11/20/25 | 821.11 on 01/09/26 |
| 6-Month | |||||
| %Chg | -45.29% since 11/28/16 | +12.29% since 07/18/25 | +14.48% since 07/18/25 | +14.71% since 07/18/25 | +35.25% since 07/18/25 |
| Low | 0.9500 on 05/11/17 | 269.77 on 09/26/25 | 42.52 on 10/29/25 | 107.75 on 07/21/25 | 541.00 on 10/13/25 |
| High | 4.2500 on 12/07/16 | 346.38 on 12/03/25 | 57.04 on 01/14/26 | 128.70 on 11/20/25 | 821.11 on 01/09/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,231 | 177,919,520 | 112,495,712 | 154,973,344 | 77,041,760 |
| Shares Outstanding, K | 3,750 | 538,481 | 2,035,753 | 1,240,680 | 105,099 |
| Annual Sales | 0 | 33,424,000,000 | 48,300,000,000 | 28,754,000,000 | 14,202,000,000 |
| Annual Net Income | -9,410,000 | 4,090,000,000 | -8,948,000,000 | 480,000,000 | 4,412,600,000 |
| Last Quarter Sales | 0 | 9,557,000,000 | 12,222,000,000 | 7,769,000,000 | 3,754,300,000 |
| Last Quarter Net Income | -1,370,000 | 3,216,000,000 | 2,201,000,000 | 3,052,000,000 | 1,460,000,000 |
| 60-Month Beta | 9.04 | 0.45 | 0.29 | 0.33 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.64 on 11/04/25 | 1.63 on 10/30/25 | 2.47 on 10/30/25 | 11.83 on 10/28/25 |
| Latest Earnings Date | 05/29/17 | 02/03/26 | 02/05/26 | 02/10/26 | 01/30/26 |
| Most Recent Dividend | N/A | 2.380 on 11/21/25 | 0.630 on 01/02/26 | 0.790 on 12/15/25 | 0.880 on 11/20/25 |
| Next Ex-Dividends Date | N/A | 02/13/26 | 01/02/26 | 12/15/25 | 11/20/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.09 | 8.63 | 14.81 | 20.23 |